Britain expects to have 10 million doses of Pfizer/BioNTech’s candidate COVID-19 vaccine available by the end of the year if regulators approve it, Prime Minister Boris Johnson’s spokesman said on Monday, following positive clinical trial results. The spokesman said that Britain had now ordered 40 million doses of the candidate vaccine developed by Pfizer Inc and BioNTech, enough to give protection to 20 million people. Speaking from Downing Street, Mr Johnson said: “If and when this vaccine is approved we in this country will be ready to start using it.
“Earlier this year the UK Government ordered 40 million doses of the Pfizer vaccination; enough for about a third of the population since you need two doses each.
“That puts us towards the front of the international pack per capita basis.
“I should add that we’ve ordered oevr 300 million doses from five other vaccine candidates as well.”
Pfizer said its experimental COVID-19 vaccine was more than 90 percent effective, a major victory in the fight against a pandemic that has killed more than a million people, battered the world’s economy and upended daily life.
We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your data protection rights.
“In total we have procured 40 million doses of the Pfizer candidate vaccine with 10 million of those doses being manufactured and available to the UK by the end of the year if the vaccine is approved by the regulators,” the spokesman said.
In all, the government has signed six supply deals for vaccine candidates, including Pfizer/BioNTech’s and one developed by Oxford University and AstraZeneca, which is also considered expected to post late-stage trial results this year.
More to follow…
Source: Read Full Article